Netflix (NASDAQ:NFLX) Price Target Reduced to $415 From $425 at Jefferies
Netflix (NASDAQ:NFLX) Price Target Reduced to $415 From $425 at Jefferies
Netflix (NASDAQ:NFLX) Price Target Reduced to $415 From $425 at Jefferies Read Post »
Netflix (NASDAQ:NFLX) Price Target Reduced to $415 From $425 at Jefferies
Netflix (NASDAQ:NFLX) Price Target Reduced to $415 From $425 at Jefferies Read Post »
JPMorgan analyst Steven Alexopoulos downgrades Comerica (NYSE:CMA) from Overweight to Neutral.
JPMorgan downgrades Comerica (NYSE:CMA) to Neutral rating Read Post »
Raymond James analyst Michael Rose upgrades Comerica (NYSE:CMA) from Outperform to Strong Buy and lowers the price target from $84 to $57.
Raymond James lowered Comerica (NYSE:CMA) price target to $57 Read Post »
Exane BNP Paribas analyst Jerome Ramel downgrades Applied Materials(NASDAQ:AMAT) from Outperform to Neutral and announces $133 price target.
Exane BNP Paribas announced Applied Materials(NASDAQ:AMAT) $133 price target Read Post »
Morgan Stanley analyst Betsy Graseck maintains Wells Fargo (NYSE:WFC) with a Overweight and lowers the price target from $58 to $47.
Morgan Stanley lowered Wells Fargo (NYSE:WFC) price target to $47 Read Post »
Raymond James analyst David Long upgrades Wells Fargo (NYSE:WFC) from Outperform to Strong Buy and lowers the price target from $52 to $47.
Raymond James lowered Wells Fargo (NYSE:WFC) price target to $47 Read Post »
Goldman Sachs analyst Jordan Alliger maintains FedEx (NYSE:FDX) with a Buy and raises the price target from $250 to $258.
Goldman Sachs raised FedEx (NYSE:FDX) price target to $258 Read Post »
Rosenblatt analyst Andrew Bond reiterates Cboe Global Markets (BATS:CBOE) with a Buy and maintains $175 price target.
Rosenblatt maintained Cboe Global Markets (BATS:CBOE) $175 price target Read Post »
Abbvie Inc. (NYSE:ABBV) said late Wednesday it expects its Q1 per-share adjusted earnings to take a $0.08 hit from acquired in-process research and development and milestones expense of $150 million on a pre-tax basis. The company expects Q1 adjusted EPS of $2.31 to $2.41, including the impact, according to a regulatory filing. Analysts surveyed by Capital IQ project $2.56 per share. For 2023, AbbVie said it now expects adjusted EPS of $10.62 to $11.02, compared with its prior range of $10.70 to $11.10. Analysts polled by Capital IQ expect $11.07 per share.
Oppenheimer analyst Timothy Horan reiterates Comcast (NASDAQ:CMCSA) with a Outperform and maintains $48 price target.
Oppenheimer maintained Comcast (NASDAQ:CMCSA) $48 price target Read Post »
Oppenheimer analyst Jason Helfstein maintains Amazon.com (NASDAQ:AMZN) with a Outperform and lowers the price target from $135 to $125.
Oppenheimer lowered Amazon.com (NASDAQ:AMZN) price target from $135 to $125 Read Post »
Barclays analyst Julian Mitchell maintains Johnson Controls Intl (NYSE:JCI) with a Equal-Weight and lowers the price target from $73 to $70.
Barclays lowered Johnson Controls Intl (NYSE:JCI) price target to $70 Read Post »